Effect of lipophilicity of Mn (III) ortho N-alkylpyridyl- and diortho N, N′-diethylimidazolylporphyrins in two in-vitro models of oxygen and glucose deprivation-induced neuronal death

Free Radical Research

Volumn 43, Issue 4, 2009, Pages 329-339

  Wise Faberowski, Lisa ^a   Warner, David S ^a   Spasojevic, Ivan ^a   Batinic Haberle, Ines ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

MnTDE 2 ImP5+ (AEOL10150); MnTE 2 PyP5+ (AEOL10113); MnTnOct 2 PyP5+; Neuronal glial cell culture; Organotypic hippocampal slices (OHS); Oxygen and glucose deprivation (OGD)

Indexed keywords

ANTIOXIDANT; DIZOCILPINE; GLUCOSE; LACTATE DEHYDROGENASE; MANGANESE; MANGANESE MESO TETRAKIS(N ETHYLPYRIDINIUM 2 YL)PORPHYRIN; MANGANESE MESO TETRAKIS(N OCTYLPYRIDINIUM 2 YL)PORPHYRIN; MANGANESE MESO TETRAKIS(N,N DIETHYLIMIDAZOLIUM 2 YL)PORPHYRIN; OCTYLPYRIDYLPORPHYRIN; OXYGEN; PORPHYRIN DERIVATIVE; PROPIDIUM IODIDE; UNCLASSIFIED DRUG; LIPID; MANGANESE TETRAKIS (N ETHYL 2 PYRIDYL) PORPHYRIN; MANGANESE TETRAKIS-(N-ETHYL-2 PYRIDYL) PORPHYRIN; METALLOPORPHYRIN; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME RELEASE; FETUS; GLIA CELL; HIPPOCAMPUS; IN VITRO STUDY; LIPOPHILICITY; MAMMAL CELL; NERVE CELL; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PARTITION COEFFICIENT; RAT; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL DEATH; CHEMISTRY; COCULTURE; DRUG EFFECT; GLIA; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

MAMMALIA; RATTUS;

ANIMALS; BIOLOGICAL AVAILABILITY; CELL DEATH; CELLS, CULTURED; COCULTURE TECHNIQUES; GLUCOSE; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; LIPIDS; MANGANESE; METALLOPORPHYRINS; MODELS, BIOLOGICAL; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67349200881     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760902736283     Document Type: Article

References (39)

1. Li, QY, Pedersen, C., Day, BD and Patel, M. (2001) Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation. J Neurochem, 78, pp. 746-755.
2. Van Empel, VPM, Bertrand, AT, Van Oort, RJ, Van der Nagel, R., Engelen, M., Van Rijen, HV, Doevendans, PA, Crijns, HJ, Ackerman, SL, Sluiter, W. and De Windt, LJ. (2006) EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J Am Coll Cardiol, 48, pp. 824-832.
3. Salvemini, D., Wang, Z-Q, Zweier, JL, Samouilov, A., Macarthur, H., Misko, TP, Curie, MG, Cuzzocrea, S., Sikorski, JA and Riley, DP. (1999) A nonpeptidyl mimic of superoxide dismutase with therapeutic activity ion rats. Science, 286, pp. 304-306.
4. Goldstein, S., Samuni, A., Hideg, K. and Merenyi, G. (2006) Structure-activity relationship of cyclic nitroxides as SOD mimics and scavengers of nitrogen dioxide and carbonate radicals. J Phys Chem A, 110, pp. 3679-3685.
5. James, AM, Cocheme, HM, Smith, RAJ and Murphy, MP. (2005) Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. J Biol Chem, 28, pp. 21295-21312.
6. Smith, RAJ, Porteous, CM, Ganes, AM and Murphy, MP. (2003) Delivery of bioactive molecules to mitochondria. Proc Natl Acad Sci USA, 100, pp. 5407-5412.
7. Batinic-Haberle, I., Benov, L., Spasojevic, I., Hambright, P., Crumbliss, AL and Fridovich, I. (1999) The relationship between redox potentials, proton dissociation constants of pyrrolic nitrogens, and in vitro and in vivo superoxide dismutase activities of Manganese(III) and Iron(III) cationic and anionic porphyrins. Inorg Chem, 38, pp. 4011-4022.
8. Reboucas, JS, DeFreitas-Silva, G., Idemori, YM, Spasojevic, I., Benov, L. and Batinic-Haberle, I. (2008) The impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins. Protection of SOD-deficient E. coli via alternative mechanism where Mn porphyrin acts as a Mn-carrier. Free Radic Biol Med, 45, pp. 201-210.
9. Batinic-Haberle, I., Spasojevic, I., Stevens, RD, Hambright, P. and Fridovich, IJ. (2002) Manganese(III) Meso Tetrakis Ortho N-alkylpyridylporphyrins. Synthesis, characterization and catalysis of dismutation. J Chem Soc Dalton Trans, pp. 2689-2696.
10. Batinic-Haberle, I., Spasojevic, I., Stevens, RD, Hambright, P., Neta, P., Okado-Matsumoto, A. and Fridovich, I. (2004) New class of potent catalysts of dismutation. Mn (III) methoxyethylpyridyl- and methoxyethylimidazolylporphyrins. Dalton Trans, pp. 1696-1702.
11. Ferrer-Sueta, G., Batinic-Haberle, I., Spasojevic, I., Fridovich, I. and Radi, R. (1999) Peroxynitrite scavanging by manganese (III) meso-tetrakis-(N-methylpyridyl) porphyrins. Chem Res Toxicol, 12, pp. 442-449.
12. Ferrer-Sueta, G., Vitturi, D., Batinic-Haberle, I., Fridovich, I., Goldstein, S., Czapski, G. and Radi, R. (2003) Reactions of manganese porphyrins with peroxynitrite and carbonate radical anion. J Biol Chem, 278, pp. 27432-27438.
13. Gauter-Fleckenstein, B., Fleckenstein, K., Owzar, K., Jian, C., Batinic-Haberle, I. and Vujaskovic, Z. (2007) Comparison of two Mn porphyrin-based mimics of superoxide-dismutase (SOD) in pulmonary radioprotection. Free Radic Biol Med, 44, pp. 982-989.
14. Vujaskovic, Z., Batinic-Haberle, I., Rabbani, ZN, Feng, Q-F, Kang, SK, Spasojevic, I., Samulski, TV, Fridovich, I., Dewhirst, MW and Anscher, MS. (2002) A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med, 33, pp. 857-863.
15. Moeller, BJ, Batinic-Haberle, I., Spasojevic, I., Rabbani, ZN, Anscher, MS, Vujaskovic, Z. and Dewhirst, MW. (2005) Effects of a catalytic metalloporphyrin antioxidant on tumor radioresponsiveness. Int J Radiat Oncol Biol Phys, 63, pp. 545-552.
16. Piganelli, JD, Flores, SC, Cruz, C., Koepp, J., Young, R., Bradley, B., Kachadourian, R., Batinic-Haberle, I. and Haskins, K. (2002) A metalloporphyrin superoxide dismutase mimetic (SOD mimetic) inhibits autoimune diabetes. Diabetes, 51, pp. 347-355.
17. Sompol, P., Ittarat, W., Tangpong, J., Chen, Y., Doubinskaia, I., Batinic-Haberle, I., Mohammad Abdul, H, Butterfield, A. and St Clair, DK. (2008) Alzheimer's disease: An insight into the mechanisms of oxidative stress-mediated mitochondrial injury. Neuroscience, 153, pp. 120-130.
18. Sheng, H., Enghild, JJ, Patel, M., Batinic-Haberle, I., Calvi, C., Day, BJ, Pearlstein, RD, Crapo, JD and Warner, DS. (2002) Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic Biol Med, 33, pp. 947-961.
19. Sheng, H., Batinic-Haberle, I. and Warner, DS. (2002) Catalytic antioxidants as novel pharmacologic approaches to treatment of ischemic brain injury. Drug News Persp, 15, pp. 654-665.
20. Leinenweber, SB, Sheng, H., Lynch, JR, Batinic-Haberle, I., Laskowitz, DT, Crapo, JD, Pearlstein, RD and Warner, DS. (2006) Effects of a manganese(III) porphyrin catalytic antioxidant in a murine model of closed head injury. Eur J Pharmacol, 531, pp. 126-132.
21. Mackensen, GB, Patel, M., Sheng, H., Calvi, C., Batinic-Haberle, I., Day, BJ, Liang, LP, Fridovich, I., Crapo, JD, Pearlstein, RD and Warner, DS. (2001) Neuroprotection from delayed post-ischemic administration of a metalloporphyrin catalytic antioxidant. J Neurosci, 21, pp. 4582-4592.
22. Batinic-Haberle, I., Ndengele, MM, Cuzzocrea, S., Reboucas, JS, Masini, E., Spasojevic, I. and Salvemini, D. (2008) Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking morphine tolerance through peroxynitrite-mediated pathways. Free Radic Biol Med, 46, pp. 212-219.
23. Okado-Matsumoto, A., Batinic-Haberle, I. and Fridovich, I. (2004) Complementation of SOD-deficient Escheria Coli by manganese porphyrin mimics of superoxide dismutase activity. Free Radic Biol Med, 37, pp. 401-410.
24. Saba, H., Batinic-Haberle, I., Munusamy, S., Mitchell, T., Lichti, C., Megyesi, J. and Mac-Millan-Crow, LA. (2007) Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion. Free Radic Biol Med, 42, pp. 1571-1578.
25. Wise-Faberowski, L., Aono, M., Pearlstein, RD and Warner, DS. (2004) Apoptosis is not enhanced in primary mixed neuronal/glial cultures protected by isoflurane against N-methyl-d-aspartate excitotoxicity. Anesth Analg, 99, pp. 1708-1714.
26. Dugan, LL, Gabrielsen, JK, Yu, SP, Lin, TS and Choi, DW. (1996) Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic cell death of cultured cortical neurons. Neurobiol Dis, 3, pp. 129-135.
27. Wise-Faberowski, L., Raizada, MK and Sumners, C. (2001) Oxygen and glucose deprivation-induced neuronal apoptosis is attenuated by halothane and isoflurane. Anesth Analg, 93, pp. 1281-1287.
28. Stoppini, L., Buch, PA and Muller, D. (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods, 37, pp. 173-182.
29. Wise-Faberowski, L., Zhang, H., Ing, R., Pearlstein, RD and Warner, DS. (2005) Isoflurane-induced neuronal degeneration: An evaluation in organotypic hippocampal slice cultures. Anesth Analg, 101, pp. 651-657.
30. Batinic-Haberle, I., Spasojevic, I., Stevens, RD, Bondurant, B., Okado-Matsumoto, A., Fridovich, I., Vujaskovic, Z. and Dewhirst, MW. (2006) New PEG-ylated Mn (III) porphyrins approaching catalytic activity of SOD enzyme. Dalton Trans, pp. 617-624.
31. Moldrich, RX, Beart, PM, Pascoe, CJ and Cheung, NS. (2000) Low-affinity kainate receptor agonists induce insult-dependent apoptosis and necrosis in cultured murine cortical neurons. J Neurosci Res, 59, pp. 788-796.
32. Cheung, NS, Beart, PM, Pascoe, CJ, John, CA and Bernard, O. (2000) Human Bcl-2 protects against AMPA receptor-mediated apoptosis. J Neurochem, 74, pp. 1613-1620.
33. Fridovich, I. (1997) Superoxide anion radical, superoxide dismutase and related matters. J Biol Chem, 272, pp. 25071-25076.
34. Warner, DS, Sheng, H. and Batinic-Haberle, I. (2004) Oxidants, antioxidants and the ischemic brain. J Exp Biol, 207, pp. 3221-3231.
35. 5+. Pharmacokinetics in mouse plasma, liver, kidney, spleen, lung, heart and brain. Free Radic Biol Med, 45, pp. 943-949.
36. 5+ targets mouse heart mitochondria. Free Radic Biol Med, 42, pp. 1193-1200.
37. Kos, I., Reboucas, JS and Batinic-Haberler, I. (2008)
38. Hansch, C., Leo, A., Mekapati, SB and Karup, A. (2004) QSAR & ADMS. Bioorg Med Chem, 12, pp. 3391-3400.
39. Proudfoot, JR. (2005) The evolution of synthetic oral drug properties. Bioorg Med Chem Lett, 15, pp. 1087-1090.